Owner AbbVie Inc.

Inventors Ding, Hong; Elmore, Steven; Hexamer, Laura; Kunzer, Aaron R.; Park, Cheol-Min; Souers, Andrew J.; Sullivan, Gerard; Wendt, Michael

Agent Spruson & Ferguson

Pub. Number AU-A-2011229862

PCT Pub. Number WO2011/119345

Priority 61/317,575 25.03.10 US

Filing date 10 March 2011

Wipo publication date 29 September 2011

C07D 295/112 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 31/18 - Sulfonamides

A61K 31/451 - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine

A61K 31/495 - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 35/00 Antineoplastic agents

C07C 311/51 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

C07D 211/58 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

C07D 295/195 Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

C07D 417/04 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group